Patrick D. Kohtz, MD, Alison L. Halpern, MD, Mohamed A

Slides:

Advertisements

Similar presentations

Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia Marshall T. Bell, MD, Viktor.

Advertisements

Kaviyanka Selvasandran, MS, Georges Makhoul, MD, MS, Prashant K

Modulation of growth in human esophageal adenocarcinoma cells by group IIa secretory phospholipase A2 David Mauchley, MD, Xianzhong Meng, MD, PhD, Thomas.

Heat shock protein 27: Induction by gastroduodenal reflux in vivo and augmentation of human esophageal mucosal cell growth in vitro David Mauchley, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition–mediated cell death in K-ras mutant lung cancer.

High-mobility group box-1 protein induces osteogenic phenotype changes in aortic valve interstitial cells Bo Wang, PhD, Fei Li, MD, Chao Zhang, PhD,

The STS National Database

Erythropoietin’s Beta Common Receptor Mediates Neuroprotection in Spinal Cord Neurons Lisa S. Foley, MD, David A. Fullerton, MD, Joshua Mares, BA, Mitchell.

Lisa S. Foley, MD, David A. Fullerton, MD, Daine T

Yi-kuan Chen, MD, Xue-mei Jiang, MSc, Jian-ping Gong, MD

Adult Aortic Valve Interstitial Cells Have Greater Responses to Toll-Like Receptor 4 Stimulation Xin-Sheng Deng, MD, Xianzhong Meng, MD, PhD, QingChun.

Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo Jessica A. Yu, MD, David Mauchley, MD, Howard Li, MD, Xianzhong.

Diabetes Upregulation of Cyclooxygenase 2 Contributes to Altered Coronary Reactivity After Cardiac Surgery Jun Feng, MD, PhD, Kelsey Anderson, Arun K.

Role of Toll-Like Receptor-4 in Lung Ischemia-Reperfusion Injury

Faraz Kerendi, MD, Paul M. Kirshbom, MD, Michael E

Combined treatment with cisplatin and sirolimus to enhance cell death in human mesothelioma Mor-Li Hartman, PhD, John Matthew Esposito, BA, Beow Yong.

Bertrand Poussier, MD, Alfredo C

The Protective Effects of Melittin on Propionibacterium acnes–Induced Inflammatory Responses In Vitro and In Vivo Woo-Ram Lee, Kyung-Hyun Kim, Hyun-Jin.

Secretory phospholipase A2 is required to produce histologic changes associated with gastroduodenal reflux in a murine model Ashok Babu, MD, Xianzhong.

Rapamycin Blocks Fibrocyte Migration and Attenuates Bronchiolitis Obliterans in a Murine Model Jacob R. Gillen, MD, Yunge Zhao, MD, PhD, David A. Harris,

Bryan A. Whitson, MD, Blake A

Meena Nathan, MD, Ingeborg Friehs, MD, Yeong-Hoon Choi, MD, Douglas B

Preclinical Studies of a Specific PPARγ Modulator in the Control of Skin Inflammation Arianna Mastrofrancesco, Daniela Kovacs, Massimiliano Sarra, Emanuela.

Short-Course Rapamycin Treatment Preserves Airway Epithelium and Protects Against Bronchiolitis Obliterans Jacob R. Gillen, MD, Yunge Zhao, MD, PhD,

Cytokines Link Toll-Like Receptor 4 Signaling to Cardiac Dysfunction After Global Myocardial Ischemia John Cha, MD, Zhiping Wang, MD, Lihua Ao, BS, Ning.

Theresa A. Reno, PhD, Jae Y. Kim, MD, Dan J. Raz, MD

Age of Transfused Red Cells and Early Outcomes After Cardiac Surgery

Potential benefit of pharmacological induction of beta common receptor

Long Esophageal Segment Laceration Caused by an Orogastric Tube During Laparoscopic Sleeve Gastrectomy Sang Kuon Lee, MD, Jongho Lee, MD The Annals.

Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: Role of Smad1 and extracellular signal-regulated.

Daniel J. Wong, MD, Daniel Y. Lu, MD, Clinton D

Castigliano M. Bhamidipati, DO, MS, George J

Pingping Ren, MD, Lin Zhang, MS, Gaiping Xu, MD, Laura C

Lipopolysaccharide Stimulation of Human Aortic Valve Interstitial Cells Activates Inflammation and Osteogenesis Ashok N. Babu, MD, Xianzhong Meng, MD,

Osteopontin-Expressing Macrophages in Non-Small Cell Lung Cancer Predict Survival Yue Li, MD, Bing-sheng Sun, MD, PhD, Baoxiang Pei, MD, Chen-guang Li,

Toll-Like Receptor 4 Mediates Lung Ischemia-Reperfusion Injury

Expression of Bone Morphogenetic Proteins in Human Lung Carcinomas

Elizabeth H. Stephens, MD, PhD, Arlene M. Correa, PhD, Min P

Toll-Like Receptor 4 Has an Essential Role in Early Skin Wound Healing

Miral R. Sadaria, MD, Amy E. Reppert, MD, Jessica A

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Lung cancer cell invasion and expression of intercellular adhesion molecule-1 (ICAM-1) are attenuated by secretory phospholipase A2 inhibition Jessica.

Who Do You Say You Are? The Annals of Thoracic Surgery

The Eumelanin Intermediate 5,6-Dihydroxyindole-2-Carboxylic Acid Is a Messenger in the Cross-Talk among Epidermal Cells Daniela Kovacs, Enrica Flori,

Paclitaxel-Loaded Expansile Nanoparticles Delay Local Recurrence in a Heterotopic Murine Non-Small Cell Lung Cancer Model Rong Liu, MD, PhD, Onkar V.

Erythropoietin activates the phosporylated cAMP [adenosine 3′5′ cyclic monophosphate] response element-binding protein pathway and attenuates delayed.

Protection by 20-5,14-HEDGE Against Surgically Induced Ischemia Reperfusion Lung Injury in Rats Irshad Ali, PhD, Stephanie Gruenloh, BS, Ying Gao, MS,

Surgical Dilemmas: Diagnosis and Treatment of Atrial Plasmacytoma

Stem Cells in Thoracic Aortic Aneurysms and Dissections: Potential Contributors to Aortic Repair Ying H. Shen, MD, PhD, Xiaoqing Hu, MD, Sili Zou, MD,

Anomalous Origin of Left Pulmonary Artery From Left Subclavian Artery

Secretory Phospholipase A2 Inhibition Attenuates Intercellular Adhesion Molecule-1 Expression in Human Esophageal Adenocarcinoma Cells Miral R. Sadaria,

Volume 68, Issue 2, Pages (August 2005)

Yunge Zhao, MD, PhD, Mark Turlington, BS, Damien J. LaPar, MD, David R

Periostin Is a Novel Factor in Cardiac Remodeling After Experimental and Clinical Unloading of the Failing Heart William E. Stansfield, MD, Nancy M.

Chadrick E. Denlinger, MD, Brian K. Rundall, DO, Michael D

Embolized Methyl Methacrylate to the Right Atrium After Kyphoplasty

Lucas W. Thornblade, MD, Aaron M. Cheng, MD, Douglas E

Editorial Board, January 2010

Completely Thrombosed Tricuspid Pouch Mimicking a Cardiac Tumor

Christine S. Rinder, MD, Michael J. Smith, PhD, Henry M

Prasun K. Datta, Elias A. Lianos Kidney International

Patrick O. Myers, MD The Annals of Thoracic Surgery

Altered Oxidative Stress Responses and Increased Type I Collagen Expression in Bicuspid Aortic Valve Patients Julie A. Phillippi, PhD, Michael A. Eskay,

Invited Commentary The Annals of Thoracic Surgery

Lipopolysaccharide-promoted proliferation of endometriotic stromal cells via induction of tumor necrosis factor α and interleukin-8 expression Yumiko.

Posttraumatic Main Left Bronchial Rupture

Spinal cord protection via alpha-2 agonist-mediated increase in glial cell-line–derived neurotrophic factor Kirsten A. Freeman, MD, David A. Fullerton,

The Impact of New Technology on Cardiothoracic Surgical Practice

Erik Madssen, RF, Petter Haere, MD, Rune Wiseth, MD, PhD

Presentation transcript:

Toll-Like Receptor-4 Is a Mediator of Proliferation in Esophageal Adenocarcinoma Patrick D. Kohtz, MD, Alison L. Halpern, MD, Mohamed A. Eldeiry, MD, Kweku Hazel, MD, Shana Kalatardi, MPH, Lihua Ao, BS, Xianzhong Meng, MD, PhD, T. Brett Reece, MD, David A. Fullerton, MD, Michael J. Weyant, MD The Annals of Thoracic Surgery Volume 107, Issue 1, Pages 233-241 (January 2019) DOI: 10.1016/j.athoracsur.2018.08.014 Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 (A) Immunofluorescence of baseline Toll-like receptor 4 (TLR4) staining for each cell line. Nuclei stained blue with 4′,6-diamidino-2-phenylindole (DAPI) and red with TLR4. The “merge” image is an overlay of the DAPI and TLR4 images (n = 1). (B) Western blot results for baseline levels of TLR4 in each respective esophageal cell line. The percent change of TLR4 expression is represented as separate ratios of OE33 and FLO-1 to HET1A. The error bars show the SEM. *p < 0.05, **p < 0.01 for comparing HET1A to OE33/FLO-1 (n = 16). (GAPDH = glyceraldehyde-3-phosphate dehydrogenase.) The Annals of Thoracic Surgery 2019 107, 233-241DOI: (10.1016/j.athoracsur.2018.08.014) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 HET1A Western blot results for Toll-like receptor 4 (TLR4) changes in response to reflux stimuli: acidic media (pH 4), 50 μmol/L deoxycholic acid (DCA), neutral media (pH 7+DCA), and acidic media with 50 μmol/L DCA (pH 4+DCA). The “percent change” of TLR4 expression is represented as a ratio of each treatment to the baseline group. The error bars show the SEM. *p < 0.01, **p < 0.001 when comparing treatments to baseline (n = 9). (GAPDH = glyceraldehyde-3-phosphate dehydrogenase.) The Annals of Thoracic Surgery 2019 107, 233-241DOI: (10.1016/j.athoracsur.2018.08.014) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 MTS proliferation assay (BioVision Inc, Milpitas, CA) results of each respective esophageal cell line with the lipopolysaccharide (LPS) concentration trial (control, 25 ng/mL, 50 ng/mL, 100 ng/mL, 200 ng/mL). Graphs are represented as a percentage change with ratios of each treatment dose to their respective control. (A) HET1A (n = 10). (B) OE33 (n = 11). (C) FLO-1 (n = 9). The error bars show the SEM. *p < 0.05, **p < 0.01, #p < 0.001 when comparing dose to control. The Annals of Thoracic Surgery 2019 107, 233-241DOI: (10.1016/j.athoracsur.2018.08.014) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Western blot results demonstrate changes in phosphorylated (p)–nuclear factor-κB (NF-κB) to total NF-κB over time with lipopolysaccharide stimulation at a standard dose of 100 ng/mL. The histogram percentage change is represented as a ratio of each treatment p–NF-κB/total NF-κB ratio to the untreated control. (A) HET1A. (B) OE33. (C) FLO-1. The error bars show the SEM. *p < 0.05, **p < 0.01, #p < 0.001 when comparing treatment time to control (n = 10). The Annals of Thoracic Surgery 2019 107, 233-241DOI: (10.1016/j.athoracsur.2018.08.014) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 5 Western blot results demonstrate changes in (left) myeloid differentiation primary response 88 (MyD88) and (right) tumor necrosis factor receptor associated factor 6 (TRAF6) over time with lipopolysaccharide stimulation at a standard dose of 100 ng/mL. The histogram percentage change is represented as a ratio of each treatment to the untreated control. (A) HET1A (n = 4). (B) OE33 (n = 5). (C) FLO-1 (n = 3). The error bars show the SEM. *p < 0.05, **p < 0.01, #p < 0.001 when comparing treatment time to control. (GAPDH = glyceraldehyde-3-phosphate dehydrogenase.) The Annals of Thoracic Surgery 2019 107, 233-241DOI: (10.1016/j.athoracsur.2018.08.014) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 6 Western blot histograms and respective immunoblots demonstrate no changes in (left) Toll-like receptor 2 (TLR2) and (right) Toll-like receptor 4 (TLR4) expression over time (2, 4, 8, and 24 hours) with lipopolysaccharide stimulation at a standard dose of 100 ng/mL. (A) HET1A (n = 9). (B) OE33 (n = 10). (C) FLO-1 (n = 8). The error bars show the SEM. (GAPDH = glyceraldehyde-3-phosphate dehydrogenase.) The Annals of Thoracic Surgery 2019 107, 233-241DOI: (10.1016/j.athoracsur.2018.08.014) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions

Fig 7 MTS proliferation assay (BioVision Inc, Milpitas, CA) results for nuclear factor (NF)-κB . Graphs are represented as a percentage change with ratios of each treatment to their respective control. #p < 0.001 when comparing treatments to dimethyl sulfoxide (DMSO); λp < 0.01, Φp < 0.001 when comparing treatments to lipopolysaccharide (LPS) only. (A) HET1A. (B) OE33. (C) FLO-1 (n = 11). (LPS 100 = lipopolysaccharide 100 ng/mL alone; NFkBi 5 = Bay11-7082 treatment dose 5 μmol/L alone; NFkBi 25 = Bay11-7082 treatment dose 25 μmol/L alone; LPS 100 + NFkBi 5 = LPS 100 ng/mL treatment combined with Bay11-7082 treatment dose 5 μmol/L; LPS 100 + NFkBi 25 = LPS 100 ng/mL treatment combined with Bay11-7082 treatment dose 25 μmol/L.) The Annals of Thoracic Surgery 2019 107, 233-241DOI: (10.1016/j.athoracsur.2018.08.014) Copyright © 2019 The Society of Thoracic Surgeons Terms and Conditions